The first case of severe avian influenza A (H7N9) in Guangdong Province in 2018 successfully treated with extracorporeal membrane oxygenation
10.3760/cma.j.issn.2095-4352.2018.12.019
- VernacularTitle:ECMO成功救治2018年广东省首例重症人感染H7N9禽流感患者
- Author:
Jianwei LI
1
;
Haiming JIANG
;
Binfei LI
;
Hongkai LIANG
;
Guishen WU
;
Xueying XU
;
Liusheng HOU
;
Miaolian CHEN
;
Zongfa RUAN
Author Information
1. 广东省中山大学附属中山医院重症医学科
- Keywords:
Avian influenza A H7N9;
Extracorporeal membrane oxygenation;
Acute respiratory distress syndrome
- From:
Chinese Critical Care Medicine
2018;30(12):1200-1201
- CountryChina
- Language:Chinese
-
Abstract:
Human infection with avian influenza A (H7N9) is easy to induce severe acute respiratory distress syndrome (ARDS), and traditional mechanical ventilation cannot correct hypoxemia, so patients may die from multiple organ failure (MOF) caused by persistent hypoxia. Extracorporeal membrane oxygenation (ECMO) can provide effective respiratory support and win time for the treatment of severe H7N9. The first case of severe H7N9 in Guangdong Province in 2018 was admitted to Zhongshan Hospital Affiliated to Sun Yat-sen University. The case was insult with severe ARDS caused by H7N9, the traditional mechanical ventilation could not correct hypoxemia, and the lung condition gradually improved with ECMO assistance. After 13 days of ECMO support, the patient was successfully weaned from ECMO and was transferred to a general ward after 55 days. After 102 days of rehabilitation, the patient was discharged from hospital and followed up for 2 months, who was in good health and had a good quality of life. This article states the diagnosis and treatment of severe H7N9 in details, providing experience for the treatment of severe H7N9 in the future.
